Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVGN | EVOGENE LTD | $32.88M | $0.65 | N/A | N/A | N/A | N/A | 519.33% | N/A | -138.50% | -32.67% | ||||
| DNA | GINKGO BIOWORKS HOLDINGS INC | $1.81B | $0.84 | $2.20 | 160.97% | Hold | 3 | 21.73% | N/A | N/A | N/A | ||||
| AKRO | AKERO THERAPEUTICS INC | $1.17B | $20.79 | $40.67 | 95.61% | Buy | 3 | N/A | N/A | N/A | N/A | ||||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $74.39M | $1.35 | $8.00 | 492.59% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| CABA | CABALETTA BIO INC | $642.58M | $13.32 | $34.33 | 157.76% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| ATXS | ASTRIA THERAPEUTICS INC | $538.05M | $9.80 | $21.75 | 121.94% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| BPMC | BLUEPRINT MEDICINES CORP | $5.55B | $90.61 | $89.10 | -1.67% | Buy | 10 | 44.37% | N/A | N/A | N/A | ||||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.80B | $16.99 | $30.20 | 77.75% | Buy | 16 | 18.02% | N/A | N/A | N/A | ||||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $1.31B | $26.39 | $50.71 | 92.17% | Strong Buy | 7 | -16.91% | N/A | N/A | N/A | ||||
| TRVI | TREVI THERAPEUTICS INC | $202.74M | $2.94 | $8.50 | 189.12% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| DMAC | DIAMEDICA THERAPEUTICS INC | $95.27M | $2.51 | $7.00 | 178.88% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| LRMR | LARIMAR THERAPEUTICS INC | $408.32M | $6.40 | $20.00 | 212.50% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| OCUL | OCULAR THERAPEUTIX INC | $754.28M | $5.08 | $16.20 | 219.21% | Buy | 5 | 36.73% | N/A | N/A | N/A | ||||
| MNKD | MANNKIND CORP | $1.11B | $4.11 | $7.00 | 70.32% | Strong Buy | 2 | 19.90% | N/A | N/A | N/A | ||||
| FOLD | AMICUS THERAPEUTICS INC | $3.20B | $10.82 | $19.00 | 75.60% | Strong Buy | 4 | 28.07% | N/A | N/A | N/A | ||||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $364.18M | $2.51 | $6.80 | 170.92% | Buy | 5 | 15.88% | N/A | N/A | N/A | ||||
| RXRX | RECURSION PHARMACEUTICALS INC | $1.78B | $7.60 | $14.33 | 88.59% | Buy | 3 | 23.96% | N/A | N/A | N/A | ||||
| PULM | PULMATRIX INC | $7.36M | $2.02 | N/A | N/A | N/A | N/A | 26.83% | N/A | N/A | N/A | ||||
| APLS | APELLIS PHARMACEUTICALS INC | $5.74B | $47.64 | $78.86 | 65.53% | Strong Buy | 14 | 58.26% | N/A | N/A | N/A | ||||
| PHAR | PHARMING GROUP NV | $665.70M | $9.92 | $37.00 | 272.98% | Buy | 1 | 12.71% | N/A | N/A | N/A | ||||
| CVAC | CUREVAC NV | $566.42M | $2.53 | N/A | N/A | N/A | N/A | 34.33% | N/A | N/A | N/A | ||||
| OCGN | OCUGEN INC | $319.08M | $1.24 | $6.00 | 383.87% | Strong Buy | 2 | 51.02% | N/A | N/A | N/A | ||||
| URGN | UROGEN PHARMA LTD | $490.33M | $14.37 | $44.00 | 206.19% | Buy | 2 | 48.09% | N/A | N/A | N/A | ||||
| CLLS | CELLECTIS SA | $146.74M | $2.64 | $6.00 | 127.27% | Buy | 1 | 55.61% | N/A | N/A | N/A | ||||
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | $1.85B | $7.37 | $10.83 | 46.99% | Strong Buy | 6 | 2.87% | N/A | N/A | N/A | ||||
| IMRN | IMMURON LTD | $14.82M | $2.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| STOK | STOKE THERAPEUTICS INC | $520.92M | $11.25 | $21.60 | 92.00% | Buy | 5 | 46.00% | N/A | N/A | N/A | ||||
| CANF | CAN-FITE BIOPHARMA LTD | $8.08M | $1.98 | $18.00 | 809.09% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| IPHA | INNATE PHARMA SA | $195.10M | $2.43 | $11.50 | 374.23% | Buy | 1 | 6.32% | N/A | N/A | N/A | ||||
| PSTX | POSEIDA THERAPEUTICS INC | $207.93M | $2.16 | $15.00 | 596.06% | Strong Buy | 2 | -6.30% | N/A | N/A | N/A | ||||
| HOOK | HOOKIPA PHARMA INC | $69.96M | $0.71 | $5.75 | 713.30% | Buy | 2 | -20.07% | N/A | N/A | N/A | ||||
| BLRX | BIOLINERX LTD | $49.29M | $0.68 | $21.00 | 3,001.92% | Buy | 1 | 99.97% | N/A | N/A | N/A | ||||
| CRVO | CERVOMED INC | $147.41M | $23.89 | $65.00 | 172.08% | Strong Buy | 1 | 21.98% | N/A | N/A | N/A | ||||
| RPTX | REPARE THERAPEUTICS INC | $137.51M | $3.26 | $10.00 | 206.75% | Buy | 1 | -23.83% | N/A | N/A | N/A | ||||
| BRTX | BIORESTORATIVE THERAPIES INC | $9.34M | $1.38 | N/A | N/A | N/A | N/A | -6.29% | N/A | N/A | N/A | ||||
| TCRT | ALAUNOS THERAPEUTICS INC | $17.45M | $1.09 | N/A | N/A | N/A | N/A | 3,044.87% | N/A | N/A | N/A | ||||
| AADI | AADI BIOSCIENCE INC | $46.65M | $1.90 | $20.50 | 978.95% | Strong Buy | 2 | 32.48% | N/A | N/A | N/A | ||||
| SILO | SILO PHARMA INC | $5.66M | $1.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| RGNX | REGENXBIO INC | $694.85M | $15.64 | $40.38 | 158.15% | Strong Buy | 8 | 38.26% | N/A | N/A | N/A | ||||
| LEXX | LEXARIA BIOSCIENCE CORP | $29.19M | $2.27 | $12.00 | 429.80% | Strong Buy | 1 | 109.85% | N/A | N/A | N/A | ||||
| ADMA | ADMA BIOLOGICS INC | $1.41B | $6.20 | $8.50 | 37.10% | Strong Buy | 3 | 19.74% | N/A | N/A | N/A | ||||
| NXTC | NEXTCURE INC | $44.92M | $1.61 | $6.00 | 272.67% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| KTTA | PASITHEA THERAPEUTICS CORP | $7.05M | $6.76 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| KURA | KURA ONCOLOGY INC | $1.38B | $18.19 | $31.75 | 74.55% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ANAB | ANAPTYSBIO INC | $526.16M | $19.66 | $44.63 | 126.98% | Buy | 8 | 34.06% | N/A | N/A | N/A | ||||
| OMGA | OMEGA THERAPEUTICS INC | $131.82M | $2.39 | $10.00 | 318.41% | Strong Buy | 4 | 306.75% | N/A | N/A | N/A | ||||
| BCAB | BIOATLA INC | $104.85M | $2.18 | $9.50 | 335.78% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| IPSC | CENTURY THERAPEUTICS INC | $197.69M | $3.05 | $15.33 | 402.72% | Strong Buy | 3 | 133.84% | N/A | N/A | N/A | ||||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.78B | $20.96 | $34.67 | 65.40% | Strong Buy | 6 | N/A | N/A | N/A | N/A | ||||
| LVTX | LAVA THERAPEUTICS NV | $74.92M | $2.85 | $6.00 | 110.53% | Buy | 1 | -18.81% | N/A | N/A | N/A | ||||
| ACET | ADICET BIO INC | $164.31M | $2.00 | $11.33 | 466.65% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| EQ | EQUILLIUM INC | $58.17M | $1.65 | $5.00 | 203.03% | Buy | 1 | -1.66% | N/A | N/A | N/A | ||||
| DYAI | DYADIC INTERNATIONAL INC | $44.33M | $1.53 | $6.00 | 292.16% | Buy | 1 | 136.33% | N/A | N/A | N/A | ||||
| LPTX | LEAP THERAPEUTICS INC | $82.18M | $3.21 | $11.38 | 254.36% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| ATHA | ATHIRA PHARMA INC | $80.10M | $2.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $922.48M | $13.00 | $33.75 | 159.62% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| VRCA | VERRICA PHARMACEUTICALS INC | $288.02M | $6.79 | $10.33 | 52.18% | Strong Buy | 3 | 201.97% | N/A | N/A | N/A | ||||
| ORIC | ORIC PHARMACEUTICALS INC | $587.52M | $8.72 | $20.20 | 131.65% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| CGEM | CULLINAN THERAPEUTICS INC | $673.12M | $15.63 | $28.75 | 83.94% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| AVIR | ATEA PHARMACEUTICALS INC | $308.88M | $3.67 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ANNX | ANNEXON INC | $409.17M | $4.55 | $16.20 | 256.44% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| CLSD | CLEARSIDE BIOMEDICAL INC | $105.36M | $1.41 | $4.75 | 236.88% | Buy | 4 | 58.37% | N/A | N/A | N/A | ||||
| ACST | ACASTI PHARMA INC | $26.79M | $2.85 | $6.00 | 110.53% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| XENE | XENON PHARMACEUTICALS INC | $3.02B | $40.01 | $59.50 | 48.71% | Strong Buy | 8 | N/A | N/A | N/A | N/A | ||||
| CRMD | CORMEDIX INC | $290.30M | $5.28 | $13.00 | 146.21% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| CGON | CG ONCOLOGY INC | $2.23B | $33.54 | $61.75 | 84.11% | Strong Buy | 4 | 630.93% | N/A | N/A | N/A | ||||
| PCVX | VAXCYTE INC | $6.68B | $61.60 | $96.00 | 55.84% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| BNTC | BENITEC BIOPHARMA INC | $17.42M | $6.72 | $16.00 | 138.10% | Buy | 1 | 1,365.21% | N/A | N/A | N/A | ||||
| LGND | LIGAND PHARMACEUTICALS INC | $1.21B | $68.53 | $119.50 | 74.38% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GLTO | GALECTO INC | $18.46M | $0.68 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CBUS | CIBUS INC | $386.11M | $16.00 | $25.00 | 56.25% | Buy | 1 | 180.74% | N/A | N/A | N/A | ||||
| SABS | SAB BIOTHERAPEUTICS INC | $40.50M | $4.39 | $15.50 | 253.08% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| VRAX | VIRAX BIOLABS GROUP LTD | $1.28M | $0.71 | N/A | N/A | N/A | N/A | 1,187.73% | N/A | N/A | N/A | ||||
| ARTL | ARTELO BIOSCIENCES INC | $4.20M | $1.30 | $5.00 | 284.62% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $259.62M | $5.02 | $14.00 | 178.88% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| PASG | PASSAGE BIO INC | $63.38M | $1.14 | $9.50 | 733.33% | Strong Buy | 2 | N/A | N/A | N/A | N/A | ||||
| PRLD | PRELUDE THERAPEUTICS INC | $211.44M | $3.85 | $5.33 | 38.52% | Hold | 3 | N/A | N/A | N/A | N/A | ||||
| PCSA | PROCESSA PHARMACEUTICALS INC | $4.37M | $1.53 | $4.00 | 161.44% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| EXAI | EXSCIENTIA PLC | $534.24M | $4.25 | $8.00 | 88.24% | Hold | 2 | 154.52% | N/A | N/A | N/A | ||||
| NRIX | NURIX THERAPEUTICS INC | $667.47M | $13.58 | $21.33 | 57.09% | Buy | 6 | 6.46% | N/A | N/A | N/A | ||||
| DOMH | DOMINARI HOLDINGS INC | $16.38M | $2.76 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| NKTX | NKARTA INC | $365.19M | $7.39 | $18.80 | 154.40% | Strong Buy | 5 | N/A | N/A | N/A | N/A | ||||
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $302.74M | $2.42 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ABEO | ABEONA THERAPEUTICS INC | $201.33M | $7.36 | N/A | N/A | N/A | N/A | 189.78% | N/A | N/A | N/A | ||||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $1.00B | $10.00 | $11.33 | 13.33% | Buy | 3 | 167.40% | N/A | N/A | N/A | ||||
| VXRT | VAXART INC | $132.48M | $0.76 | $2.00 | 162.47% | Strong Buy | 1 | 111.69% | N/A | N/A | N/A | ||||
| LTRN | LANTERN PHARMA INC | $61.44M | $5.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| PMVP | PMV PHARMACEUTICALS INC | $89.00M | $1.73 | $5.67 | 227.57% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| XBIT | XBIOTECH INC | $242.08M | $7.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| LENZ | LENZ THERAPEUTICS INC | $132.20M | $15.89 | $31.33 | 97.19% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| STRO | SUTRO BIOPHARMA INC | $235.41M | $3.77 | $13.14 | 248.62% | Strong Buy | 7 | -29.78% | N/A | N/A | N/A | ||||
| TYRA | TYRA BIOSCIENCES INC | $814.08M | $15.50 | $25.50 | 64.52% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| GDTC | CYTOMED THERAPEUTICS LTD | $25.97M | $2.25 | $5.00 | 122.22% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| GPCR | STRUCTURE THERAPEUTICS INC | $1.68B | $36.02 | $83.00 | 130.43% | Strong Buy | 3 | N/A | N/A | N/A | N/A | ||||
| ALDX | ALDEYRA THERAPEUTICS INC | $231.46M | $3.93 | $10.00 | 154.45% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| THRD | THIRD HARMONIC BIO INC | $474.32M | $11.65 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CMPX | COMPASS THERAPEUTICS INC | $205.01M | $1.49 | $9.00 | 504.03% | Buy | 2 | N/A | N/A | N/A | N/A | ||||
| VOR | VOR BIOPHARMA INC | $124.07M | $1.82 | $13.50 | 641.76% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| ERAS | ERASCA INC | $280.26M | $1.85 | $7.20 | 289.19% | Buy | 5 | N/A | N/A | N/A | N/A | ||||
| EPIX | ESSA PHARMA INC | $283.12M | $6.40 | $17.00 | 165.63% | Buy | 1 | N/A | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.